Search Clinical Trials
583,695 trials
ID
Status
Phase
Title
Sponsor
NCT07576023
A 4-weeks Comparative Study of Cosmetic Product Versus Standard Medical Care in Subjects With Seborrheic DermatitisPierre Fabre Dermo CosmetiqueCompletedNot Applicable
NCT07576023Completed
Not Applicable
A 4-weeks Comparative Study of Cosmetic Product Versus Standard Medical Care in...Pierre Fabre Dermo Cosmet...
NCT07576725
Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO TrialFred Hutchinson Cancer CenterNot Yet RecruitingPhase 2
NCT07576725Not Yet Recruiting
Phase 2
Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metas...Fred Hutchinson Cancer Ce...
NCT07576010
Steroids Combined With Ruxolitinib as First-Line Therapy for Grade II Acute Graft-versus-Host DiseaseDaihong LiuActive Not RecruitingPhase 1
NCT07576010Active Not Recruiting
Phase 1
Steroids Combined With Ruxolitinib as First-Line Therapy for Grade II Acute Graf...Daihong Liu
NCT07575256
Multicenter Clinical Study on Robotic-Assisted Surgical Management of Posterior Cruciate Ligament Tibial Avulsion FracturesBeijing Tsinghua Chang Gung HospitalNot Yet RecruitingNot Applicable
NCT07575256Not Yet Recruiting
Not Applicable
Multicenter Clinical Study on Robotic-Assisted Surgical Management of Posterior...Beijing Tsinghua Chang Gu...
NCT07575191
Safety and Performance of a Novel Infusion Catheter System for Peri/Intratumoral Gemcitabine Delivery in Patients With Pancreatic CancerSmartwise Sweden ABNot Yet RecruitingPhase 1
NCT07575191Not Yet Recruiting
Phase 1
Safety and Performance of a Novel Infusion Catheter System for Peri/Intratumoral...Smartwise Sweden AB
NCT07574801
Postoperative Pain Following Root Canal Treatment With Bioceramic SealersCairo UniversityNot Yet RecruitingNot Applicable
NCT07574801Not Yet Recruiting
Not Applicable
Postoperative Pain Following Root Canal Treatment With Bioceramic SealersCairo University
NCT07574957
Prediction of Peritoneal Dissemination of Digestive Tumors Through the Study of Circulating Tumor DNAAssistance Publique - Hôpitaux de ParisNot Yet Recruiting
NCT07574957Not Yet Recruiting
—
Prediction of Peritoneal Dissemination of Digestive Tumors Through the Study of...Assistance Publique - Hôp...
NCT07574840
Allogeneic Dental Pulp Stem Cells for the Treatment of PeriodontitisThe First Affiliated Hospital of Xinxiang Medical CollegeNot Yet RecruitingNot Applicable
NCT07574840Not Yet Recruiting
Not Applicable
Allogeneic Dental Pulp Stem Cells for the Treatment of PeriodontitisThe First Affiliated Hosp...
NCT07575581
Psychometric Evaluation of the EVARUCI Scale in Turkish Intensive Care UnitsIstanbul UniversityCompleted
NCT07575581Completed
—
Psychometric Evaluation of the EVARUCI Scale in Turkish Intensive Care UnitsIstanbul University
NCT07576400
Dietary Interventions in the Secondary Prevention of Myocardial Infarction: Focus on Plant-Based NutritionMasaryk UniversityCompletedNot Applicable
NCT07576400Completed
Not Applicable
Dietary Interventions in the Secondary Prevention of Myocardial Infarction: Focu...Masaryk University
NCT07575880
Screening for Obstructive Respiratory Disorders in the General Population During the "Mai Poumon 2026" Prevention Campaign: Prevalence and Impact on the Care PathwayCentre Hospitalier de la côte BasqueNot Yet Recruiting
NCT07575880Not Yet Recruiting
—
Screening for Obstructive Respiratory Disorders in the General Population During...Centre Hospitalier de la...
NCT07574814
Effect of Self-assembly Peptide With or Without Laser on Remineralization of Initial CariousDelta University for Science and TechnologyCompletedNot Applicable
NCT07574814Completed
Not Applicable
Effect of Self-assembly Peptide With or Without Laser on Remineralization of Ini...Delta University for Scie...
NCT07576049
COLORECTAL CANCER: SINGLE CENTER EXPERIENCEUniversity of Roma La SapienzaEnrolling By Invitation
NCT07576049Enrolling By Invitation
—
COLORECTAL CANCER: SINGLE CENTER EXPERIENCEUniversity of Roma La Sap...
NCT07574970
A COMBINATION OF RECTAL INDOMETHACIN AND COLD -WATER EXPOSURE OF THE AMPULLA AFTER ERCP IS SUPERIOR TO RECTAL INDOMETHACIN ALONE IN REDUCING THE INCIDENCE OF POST-ERCP PANCREATITIS - A PILOT RCT IN INDIAN POPULATIONAsian Institute of Gastroenterology, IndiaRecruiting
NCT07574970Recruiting
—
A COMBINATION OF RECTAL INDOMETHACIN AND COLD -WATER EXPOSURE OF THE AMPULLA AFT...Asian Institute of Gastro...
NCT07576647
Optimized Recruitment to Drive Equitable Research in Stroke, Empowering Decision-making (ORDERed)McMaster UniversityNot Yet RecruitingNot Applicable
NCT07576647Not Yet Recruiting
Not Applicable
Optimized Recruitment to Drive Equitable Research in Stroke, Empowering Decision...McMaster University
NCT07576842
Testing the Feasibility of Different HPV Screening and Care Strategies for Women Living With HIVBeth Israel Deaconess Medical CenterNot Yet RecruitingNot Applicable
NCT07576842Not Yet Recruiting
Not Applicable
Testing the Feasibility of Different HPV Screening and Care Strategies for Women...Beth Israel Deaconess Med...
NCT07576062
Efficacy of Cognitive Functional Therapy in Individuals With Chronic Low Back Pain After Spinal SurgeryCentro Universitário Augusto MottaNot Yet RecruitingNot Applicable
NCT07576062Not Yet Recruiting
Not Applicable
Efficacy of Cognitive Functional Therapy in Individuals With Chronic Low Back Pa...Centro Universitário Augu...
NCT07574450
Taiwan ED Airway Quality Surveillance Registry (TEAR)Chang Gung Memorial HospitalNot Yet Recruiting
NCT07574450Not Yet Recruiting
—
Taiwan ED Airway Quality Surveillance Registry (TEAR)Chang Gung Memorial Hospi...
NCT07576569
Nursing Intervention for Adaptation After Myocardial RevascularizationUniversidad de la SabanaNot Yet RecruitingNot Applicable
NCT07576569Not Yet Recruiting
Not Applicable
Nursing Intervention for Adaptation After Myocardial RevascularizationUniversidad de la Sabana
Result Breakdown
Not yet recruiting12 (60%)
Completed4 (20%)
Active, not recruiting2 (10%)
Enrolling by invitation1 (5%)
Recruiting1 (5%)
not_applicable10 (50%)
Not Specified7 (35%)
Phase 12 (10%)
Phase 21 (5%)